
Results
113
113 companies
Celcuity
Market Cap: US$4.9b
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$99.95
7D
11.1%
1Y
648.7%
AIRO Group Holdings
Market Cap: US$217.9m
A multi-faceted advanced Aerospace and Defense company in the United States, Europe, and internationally.
AIRO
US$6.93
7D
-9.9%
1Y
-71.2%
NeurAxis
Market Cap: US$90.0m
A medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
NRXS
US$7.27
7D
1.5%
1Y
200.4%
Legend Biotech
Market Cap: US$5.5b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$28.69
7D
-2.2%
1Y
-19.2%
Oscar Health
Market Cap: US$9.0b
Operates as a healthcare technology company in the United States.
OSCR
US$29.79
7D
4.4%
1Y
38.9%